DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Peeters M, Price TJ, Cervantes A. et al.
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
J Clin Oncol 2010;
28 (31) 4706-4713
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.